110 related articles for article (PubMed ID: 33468932)
1. [Two Cases of Breast Cancer with Extensive Invasion to Skin].
Maruo K; Nishimori T; Takemura S; Sakurai Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2275-2277. PubMed ID: 33468932
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Dermatitis Caused by Metronidazole Gel That Needed to Be Differentiated from Breast Cancer Skin Metastasis].
Ishihara S; Kashiwagi S; Asano Y; Kawano Y; Kouhashi R; Yabumoto A; Tauchi Y; Morisaki T; Noda S; Takashima T; Onoda N; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2089-2091. PubMed ID: 33468810
[TBL] [Abstract][Full Text] [Related]
3. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
4. [Mastectomy Followed by Skin-Transplantation Restored QOL and Enabled Chemotherapy in Two Cases of Locally Advanced Breast Cancer with Uncontrollable Bleeding].
Yoshimura A; Harada S; Ueda T; Tanaka T; Yokoyama T; Nakanishi T; Miyata R; Okazaki A
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1942-1944. PubMed ID: 33468760
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
[TBL] [Abstract][Full Text] [Related]
6. Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Coudert B; Pierga JY; Mouret-Reynier MA; Kerrou K; Ferrero JM; Petit T; Kerbrat P; Dupré PF; Bachelot T; Gabelle P; Giard S; Coeffic D; Bougnoux P; Prevost JB; Paintaud G; Thibault G; Hernandez J; Coudert M; Arnould L; Berriolo-Riedinger A
Lancet Oncol; 2014 Dec; 15(13):1493-1502. PubMed ID: 25456368
[TBL] [Abstract][Full Text] [Related]
7. [Two Cases of Carcinoma en Cuirasse, as Cutaneous Metastasis of Breast Cancer].
Kimura A; Inoue S; Maruyama T; Nakayama Y; Omori M; Nakada H; Ashizawa N; Kawaguchi Y; Hosomura N; Kono H; Ichikawa D
Gan To Kagaku Ryoho; 2022 Jan; 49(1):85-87. PubMed ID: 35046370
[TBL] [Abstract][Full Text] [Related]
8. Hyperbaric oxygen therapy for a refractory skin ulcer after radical mastectomy and radiation therapy: a case report.
Enomoto M; Yagishita K; Okuma K; Oyaizu T; Kojima Y; Okubo A; Maeda T; Miyamoto S; Okawa A
J Med Case Rep; 2017 Jan; 11(1):5. PubMed ID: 28049509
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Advanced Breast Cancer Effectively Treated with Bevacizumab and Letrozole].
Hara Y; Sakurai K; Adachi K; Fujiwara A; Ono Y; Waga E; Hirano T; Enomoto K
Gan To Kagaku Ryoho; 2018 Feb; 45(2):368-370. PubMed ID: 29483450
[TBL] [Abstract][Full Text] [Related]
10. [A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome].
Tashima Y; Kusanagi K; Takeda Y; Yoshimatsu K; Ishida T; Shinohara S; Hirai A; Imanishi N; Ichiki Y; Tanaka F
J UOEH; 2019; 41(2):211-216. PubMed ID: 31292366
[TBL] [Abstract][Full Text] [Related]
11. [Late Recurrence of Breast Cancer 32 Years after Surgery-A Case Report].
Takada K; Kashiwagi S; Kawajiri H; Asano Y; Morisaki T; Noda S; Takashima T; Onoda N; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2210-2212. PubMed ID: 32156881
[TBL] [Abstract][Full Text] [Related]
12. Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer.
Schwartzberg LS; Badarinath S; Keaton MR; Childs BH
Clin Breast Cancer; 2014 Jun; 14(3):161-8. PubMed ID: 24566467
[TBL] [Abstract][Full Text] [Related]
13. [Remarkable improvement in a patient with metastatic and locally advanced HER2-positive breast cancer treated with trastuzumab plus vinorelbine].
Kanazawa S; Ogata H; Magoshi S; Saito F; Ito T; Kubota Y; Kaneko H
Gan To Kagaku Ryoho; 2012 Mar; 39(3):445-9. PubMed ID: 22421777
[TBL] [Abstract][Full Text] [Related]
14. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
15. [A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].
Yoshibayashi H; Ishiguro H; Takada M; Takeuchi M; Yamashiro H; Ueno T; Kato H; Yoshikawa K; Kanao S; Yamauchi C; Mikami Y; Toi M
Gan To Kagaku Ryoho; 2008 Jun; 35(6):987-90. PubMed ID: 18633230
[TBL] [Abstract][Full Text] [Related]
16. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Smith JW; Buyse ME; Rastogi P; Geyer CE; Jacobs SA; Patocskai EJ; Robidoux A; Conlin AK; Ansari B; Keogh GP; Stella PJ; Gross HM; Lord RS; Polikoff JA; Mauquoi C; Mamounas EP; Swain SM; Wolmark N
Clin Breast Cancer; 2017 Feb; 17(1):48-54.e3. PubMed ID: 27693116
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
Morishita A; Mitsuhashi S; Fujisawa F; Hirano M; Kojima H
Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
[TBL] [Abstract][Full Text] [Related]
18. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
Inoue Y; Yamashita N; Tokunaga E; Tanaka K; Ueo H; Saeki H; Oki E; Yamamoto H; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1917-1921. PubMed ID: 28373460
[TBL] [Abstract][Full Text] [Related]
19. [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1525-8. PubMed ID: 19755825
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Bertucci F; Fekih M; Autret A; Petit T; Dalenc F; Levy C; Romieu G; Bonneterre J; Ferrero JM; Kerbrat P; Soulie P; Mouret-Reynier MA; Bachelot T; Lerebours F; Eymard JC; Deblock M; Lortholary A; Hardy-Bessard AC; Barthelemy P; Bonnefoi H; Charafe-Jauffret E; Bidard FC; Viens P; Lemonnier J; Pierga JY
Lancet Oncol; 2016 May; 17(5):600-11. PubMed ID: 27032301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
